Melissa Krebs Shares GelSana’s Vision for Innovative Wound Care Solutions

In an interview with Pharmaceutical Executive, Melissa Krebs, Ph.D., the CEO and founder of GelSana, discusses her journey in developing novel biomaterials that aim to revolutionize the $78 billion wound care market. Krebs, a chemical engineer and biomedical researcher, has dedicated her career to advancing the field of biomaterials and their application in wound care. As the CEO and founder of GelSana, a startup based at Fitzsimons Innovation Community in Aurora, Colorado, Krebs is leading the charge in developing innovative polymer-based solutions that address the underlying biological challenges of chronic wounds. With a strong background in academia and industry experience, Krebs has leveraged her expertise to create materials that can reduce inflammation, repel bacteria, and facilitate controlled drug delivery—all with the goal of accelerating the healing process and improving patient outcomes:

• 00:22 - Krebs' journey and background that led her to start GelSana
• 01:41 - Overview of GelSana and the company's wound care technology
• 03:14 - Explanation of GelSana's polymer technology and how it addresses wound healing
• 04:33 - Potential impact of GelSana's technology on the $78 billion annual wound care market
• 05:50 - GelSana's grants and awards, and how they support the company's development
• 07:04 - GelSana's focus on military applications of their technology
• 07:23 - GelSana's aspirations for improving patient care, experience, and cost
• 08:32 - Updates on GelSana's growth, fundraising, and upcoming product launch